Advanced Genomics is a leading, Canadian based biotech research and development company, and complete health solutions provider. Healthcare reform is a serious and important issue in the government right now due to increasing cost of drugs and treatments, more side effects, and increasing number of adverse drug reactions. The reason is most of the diseases are not diagnosed properly and are not cured at an early stage. Prescribed drugs are effective only in 40-50% patient population and are not effective in the rest of the population, leading only to side effects and adverse drug reactions. All these factors lead to an advanced stage of disease that is difficult to treat. We at Advanced Genomics are very serious about addressing all these issues in our business. With our two decades of molecular research experience, we strongly believe that genomics has the potential to solve these problems. Our advanced technologies, and synergistic genomics and bioinformatics approaches unlock the secrets of genes and attracts substantial resources for the development of better diagnostics, safe and cost effective drugs along with personalized treatment procedures. Our mission is to move health care management from a control or treat model of disease, to a control overall status model of disease.

Some of the diseases are inherited but for most of the diseases, genes, foods and environmental factors play a large contributing role. Excessive amount of toxins, pollutants, and high stress life styles can zap the immune system. In addition, poor quality food full of pesticides and pathogens contribute to most of the chronic diseases like cancer, diabetes mellitus, and many other diseases. Advanced Genomics is well positioned to take these three factors into consideration and we have developed a hybrid business model that blends fee-for service projects and research and development collaborations in four diverse but integrated domains:

• AdGen Medical –personalized medicine
• AdGen Pharma –pharmacogenomics
• AdGen Enviro ­  –metagenomics and forest genomics
• AdGen Nutri      –nutrigenomics

At Advanced Genomics through our dedication to innovation and scientific excellence, we have developed two pipelines:

Research and Discovery: Advanced Genomics is well positioned to rapidly deploy its proven technology to respond to infectious diseases, diabetes, and various types of cancers. Our product development includes early research which encompasses the entire spectrum of genomic biomarkers discovery, predictive diagnosis, and analysis of drug response and drug toxicity. We continue to pursue innovative research and new opportunities beyond our targeted disease areas.

Complete Solution: Advanced Genomics offers a complete solution right across the value chain, from identification of lead candidate to gene testing. Our expert personnel specialize in a wide range of services starting form wet lab basic research to microarray experimental procedures, data acquisition and analysis, bioinformatics, and database management. We have developed methods to process nanogram sample to distinct disease signatures, and high resolution whole- genome print to improve and speed up clinical applications for health.

Genome based research information from four domains of Advanced Genomics will be gathered together in a database to find out the relationship between these factors to form a disease and also will be used for the improvement of various fields of medicine, pharmaceuticals, environment and nutrition.

Collaborations: We are building deep, long-term collaborations with eminent researchers and medical professionals with similar vision to strengthen the healthcare system.  We are preparing the opportunity for new, multi-center functional genomics research projects, stimulating technology innovation and industrial collaborations. You can have access to our expertise and resources to turn tissue, blood, and culture samples to distinct disease signatures that enable you to find sustainable and cost-effective solutions for the 21st century health challenges. The information obtained from this genome based research will affect the future development of various fields of medicine, pharmaceuticals, and agriculture.